Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-08-04

AUTHORS

K K McLaurin, A M Farr, S W Wade, D R Diakun, D L Stewart

ABSTRACT

OBJECTIVE: Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions. STUDY DESIGN: This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29-30, 31-32, 33-34 and 35-36 weeks' gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted. RESULTS: There were 1 683 188 infants insured through Medicaid and 1 663 832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29 967 Medicaid-insured infants and 16 310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10 570 for full-term infants to $15 839 and $19 931 for preterm infants 33-34 wGA, and to $39 354 and $40 813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35 000 to $89 000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants. CONCLUSIONS: Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups. More... »

PAGES

990-996

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/jp.2016.113

DOI

http://dx.doi.org/10.1038/jp.2016.113

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007747632

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27490190


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gestational Age", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Newborn", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Premature", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insurance, Health", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units, Neonatal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Length of Stay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medicaid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Syncytial Virus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA.", 
          "id": "http://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "McLaurin", 
        "givenName": "K K", 
        "id": "sg:person.01116472424.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116472424.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA.", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farr", 
        "givenName": "A M", 
        "id": "sg:person.014011544305.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011544305.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA.", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wade", 
        "givenName": "S W", 
        "id": "sg:person.0617012057.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA.", 
          "id": "http://www.grid.ac/institutes/grid.460065.1", 
          "name": [
            "Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diakun", 
        "givenName": "D R", 
        "id": "sg:person.015404505305.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404505305.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children's Hospital, Louisville, KY, USA.", 
          "id": "http://www.grid.ac/institutes/grid.266623.5", 
          "name": [
            "Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children's Hospital, Louisville, KY, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stewart", 
        "givenName": "D L", 
        "type": "Person"
      }
    ], 
    "datePublished": "2016-08-04", 
    "datePublishedReg": "2016-08-04", 
    "description": "OBJECTIVE: Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions.\nSTUDY DESIGN: This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29-30, 31-32, 33-34 and 35-36 weeks' gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted.\nRESULTS: There were 1\u2009683\u2009188 infants insured through Medicaid and 1\u2009663\u2009832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29\u2009967 Medicaid-insured infants and 16\u2009310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10\u2009570 for full-term infants to $15\u2009839 and $19\u2009931 for preterm infants 33-34 wGA, and to $39\u2009354 and $40\u2009813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35\u2009000 to $89\u2009000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants.\nCONCLUSIONS: Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/jp.2016.113", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1095220", 
        "issn": [
          "0743-8346", 
          "1476-5543"
        ], 
        "name": "Journal of Perinatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "full-term infants", 
      "intensive care unit", 
      "respiratory syncytial virus", 
      "RSV hospitalization", 
      "preterm infants", 
      "mechanical ventilation", 
      "days of age", 
      "comorbid conditions", 
      "care unit", 
      "hospitalization costs", 
      "inpatient claims", 
      "chronologic age", 
      "use of MV", 
      "lower respiratory tract infections", 
      "Multi-State Medicaid", 
      "preterm infants 33", 
      "respiratory tract infections", 
      "chronic lung disease", 
      "cause of hospitalization", 
      "length of stay", 
      "first year", 
      "younger chronologic age", 
      "high-risk conditions", 
      "health care claims", 
      "health care policy", 
      "hospital severity", 
      "infants 33", 
      "PICU admission", 
      "tract infections", 
      "RSV infection", 
      "premature infants", 
      "premature birth", 
      "hospitalization outcomes", 
      "syncytial virus", 
      "lung disease", 
      "infant subgroups", 
      "Encounters Database", 
      "diagnosis codes", 
      "risk factors", 
      "clinical guidelines", 
      "Commercial Claims", 
      "hospitalization", 
      "mean cost", 
      "full term", 
      "diagnostic coding", 
      "infants", 
      "older infants", 
      "Medicaid", 
      "infection", 
      "severity", 
      "preterm", 
      "age", 
      "commercial plans", 
      "longer length", 
      "stay", 
      "admission", 
      "higher proportion", 
      "birth", 
      "separate analysis", 
      "years", 
      "days", 
      "statistical comparison", 
      "important differences", 
      "disease", 
      "ventilation", 
      "life", 
      "outcomes", 
      "virus", 
      "United States", 
      "presence of code", 
      "subgroups", 
      "differences", 
      "risk", 
      "children", 
      "cause", 
      "database", 
      "guidelines", 
      "group", 
      "findings", 
      "proportion", 
      "use", 
      "factors", 
      "data", 
      "commercial groups", 
      "study", 
      "analysis", 
      "units", 
      "measures", 
      "length", 
      "presence", 
      "objective", 
      "conditions", 
      "plan", 
      "time", 
      "availability of data", 
      "USD", 
      "comparison", 
      "cost", 
      "availability", 
      "claims", 
      "terms", 
      "state", 
      "position", 
      "policy", 
      "coding", 
      "code", 
      "RSV hospitalization costs", 
      "Truven Health Market Scan Multi-State Medicaid", 
      "Health Market Scan Multi-State Medicaid", 
      "Market Scan Multi-State Medicaid", 
      "Scan Multi-State Medicaid", 
      "first-year RSV hospitalization costs", 
      "severe RSV hospitalizations", 
      "first-year RSV hospitalizations", 
      "Respiratory syncytial virus hospitalization outcomes", 
      "syncytial virus hospitalization outcomes", 
      "virus hospitalization outcomes"
    ], 
    "name": "Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants", 
    "pagination": "990-996", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007747632"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/jp.2016.113"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27490190"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/jp.2016.113", 
      "https://app.dimensions.ai/details/publication/pub.1007747632"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_690.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/jp.2016.113"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'


 

This table displays all metadata directly associated to this object as RDF triples.

289 TRIPLES      21 PREDICATES      161 URIs      153 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/jp.2016.113 schema:about N00a88ba00728451ca7a51cfa79b2cbc9
2 N0894c382fb7548b8afda8bbbc60e7100
3 N1519615fd6b54274b81eb75ce3bff0fa
4 N29518d4e69ac41bc9b57f508b3bfa94c
5 N43720dc044b14898b150438e6f2355eb
6 N4445438fe733434c8127bed4192a1226
7 N48f4b6bf584d41579603a8665d306a77
8 N554bc404a0b44987b03b8f2655aebcbf
9 N6405992629034172b5cd891e44c20332
10 N70a99c6dc26a4572a4b1887d5bc2b9bd
11 N926d63e0135b4b63b280a3a64d55744f
12 N9ee44e0331814dc0b4a4abac54a9894b
13 Na54cac2047604141817948982eccb3e7
14 Nb9d9b1ee7c6e437a891a54318100652a
15 Ned73886424de4fa39eb1d67550872d15
16 Neda36ad8324742afba5d6f26720aac35
17 Nf05ac12de9d0465a9e97e6b0f8e856a9
18 Nf2ff0e08ea8e42a292683f63141d1517
19 anzsrc-for:11
20 anzsrc-for:1114
21 schema:author Nf7ee38cc4186441b83c17f9b1ae3c058
22 schema:datePublished 2016-08-04
23 schema:datePublishedReg 2016-08-04
24 schema:description OBJECTIVE: Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions. STUDY DESIGN: This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29-30, 31-32, 33-34 and 35-36 weeks' gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted. RESULTS: There were 1 683 188 infants insured through Medicaid and 1 663 832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29 967 Medicaid-insured infants and 16 310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10 570 for full-term infants to $15 839 and $19 931 for preterm infants 33-34 wGA, and to $39 354 and $40 813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35 000 to $89 000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants. CONCLUSIONS: Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf N3dcbb00e78fe4af58a4e8f6c0fa43bff
29 Nf4a0f439b559462891cc96a516c99142
30 sg:journal.1095220
31 schema:keywords Commercial Claims
32 Encounters Database
33 Health Market Scan Multi-State Medicaid
34 Market Scan Multi-State Medicaid
35 Medicaid
36 Multi-State Medicaid
37 PICU admission
38 RSV hospitalization
39 RSV hospitalization costs
40 RSV infection
41 Respiratory syncytial virus hospitalization outcomes
42 Scan Multi-State Medicaid
43 Truven Health Market Scan Multi-State Medicaid
44 USD
45 United States
46 admission
47 age
48 analysis
49 availability
50 availability of data
51 birth
52 care unit
53 cause
54 cause of hospitalization
55 children
56 chronic lung disease
57 chronologic age
58 claims
59 clinical guidelines
60 code
61 coding
62 commercial groups
63 commercial plans
64 comorbid conditions
65 comparison
66 conditions
67 cost
68 data
69 database
70 days
71 days of age
72 diagnosis codes
73 diagnostic coding
74 differences
75 disease
76 factors
77 findings
78 first year
79 first-year RSV hospitalization costs
80 first-year RSV hospitalizations
81 full term
82 full-term infants
83 group
84 guidelines
85 health care claims
86 health care policy
87 high-risk conditions
88 higher proportion
89 hospital severity
90 hospitalization
91 hospitalization costs
92 hospitalization outcomes
93 important differences
94 infant subgroups
95 infants
96 infants 33
97 infection
98 inpatient claims
99 intensive care unit
100 length
101 length of stay
102 life
103 longer length
104 lower respiratory tract infections
105 lung disease
106 mean cost
107 measures
108 mechanical ventilation
109 objective
110 older infants
111 outcomes
112 plan
113 policy
114 position
115 premature birth
116 premature infants
117 presence
118 presence of code
119 preterm
120 preterm infants
121 preterm infants 33
122 proportion
123 respiratory syncytial virus
124 respiratory tract infections
125 risk
126 risk factors
127 separate analysis
128 severe RSV hospitalizations
129 severity
130 state
131 statistical comparison
132 stay
133 study
134 subgroups
135 syncytial virus
136 syncytial virus hospitalization outcomes
137 terms
138 time
139 tract infections
140 units
141 use
142 use of MV
143 ventilation
144 virus
145 virus hospitalization outcomes
146 years
147 younger chronologic age
148 schema:name Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants
149 schema:pagination 990-996
150 schema:productId N6d4d4fc6414e4cca9681a9fad1cd63b7
151 Nb56bae74c0d243a28155c15bab0dbaa0
152 Ndf9795697d9a4d7cbb7af227b77f216c
153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007747632
154 https://doi.org/10.1038/jp.2016.113
155 schema:sdDatePublished 2022-01-01T18:40
156 schema:sdLicense https://scigraph.springernature.com/explorer/license/
157 schema:sdPublisher Nfc2461f4fef841efa765f06b09e5b40c
158 schema:url https://doi.org/10.1038/jp.2016.113
159 sgo:license sg:explorer/license/
160 sgo:sdDataset articles
161 rdf:type schema:ScholarlyArticle
162 N00a88ba00728451ca7a51cfa79b2cbc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Infant
164 rdf:type schema:DefinedTerm
165 N0894c382fb7548b8afda8bbbc60e7100 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Risk Factors
167 rdf:type schema:DefinedTerm
168 N1519615fd6b54274b81eb75ce3bff0fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Respiratory Syncytial Virus Infections
170 rdf:type schema:DefinedTerm
171 N1522167bb20d4812ba4d3cb28ddcb7e0 rdf:first N9ed13bda978344b4b89c8c9177c4ba05
172 rdf:rest rdf:nil
173 N29518d4e69ac41bc9b57f508b3bfa94c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 N3dcbb00e78fe4af58a4e8f6c0fa43bff schema:issueNumber 11
177 rdf:type schema:PublicationIssue
178 N43720dc044b14898b150438e6f2355eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Insurance, Health
180 rdf:type schema:DefinedTerm
181 N4445438fe733434c8127bed4192a1226 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name United States
183 rdf:type schema:DefinedTerm
184 N48f4b6bf584d41579603a8665d306a77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Male
186 rdf:type schema:DefinedTerm
187 N5450a3df2b994869bcdcb3b15a00dc20 rdf:first sg:person.0617012057.00
188 rdf:rest Nf0aaa6f5ed0b450e9be4278147b7c634
189 N554bc404a0b44987b03b8f2655aebcbf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Gestational Age
191 rdf:type schema:DefinedTerm
192 N6405992629034172b5cd891e44c20332 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Intensive Care Units, Neonatal
194 rdf:type schema:DefinedTerm
195 N6d4d4fc6414e4cca9681a9fad1cd63b7 schema:name pubmed_id
196 schema:value 27490190
197 rdf:type schema:PropertyValue
198 N70a99c6dc26a4572a4b1887d5bc2b9bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Severity of Illness Index
200 rdf:type schema:DefinedTerm
201 N926d63e0135b4b63b280a3a64d55744f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Medicaid
203 rdf:type schema:DefinedTerm
204 N9ed13bda978344b4b89c8c9177c4ba05 schema:affiliation grid-institutes:grid.266623.5
205 schema:familyName Stewart
206 schema:givenName D L
207 rdf:type schema:Person
208 N9ee44e0331814dc0b4a4abac54a9894b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Female
210 rdf:type schema:DefinedTerm
211 Na54cac2047604141817948982eccb3e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Infant, Newborn
213 rdf:type schema:DefinedTerm
214 Nb56bae74c0d243a28155c15bab0dbaa0 schema:name dimensions_id
215 schema:value pub.1007747632
216 rdf:type schema:PropertyValue
217 Nb9d9b1ee7c6e437a891a54318100652a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Databases, Factual
219 rdf:type schema:DefinedTerm
220 Nd7d00306804e42f4a75e0156ec90354a rdf:first sg:person.014011544305.49
221 rdf:rest N5450a3df2b994869bcdcb3b15a00dc20
222 Ndf9795697d9a4d7cbb7af227b77f216c schema:name doi
223 schema:value 10.1038/jp.2016.113
224 rdf:type schema:PropertyValue
225 Ned73886424de4fa39eb1d67550872d15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Age Factors
227 rdf:type schema:DefinedTerm
228 Neda36ad8324742afba5d6f26720aac35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Hospitalization
230 rdf:type schema:DefinedTerm
231 Nf05ac12de9d0465a9e97e6b0f8e856a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Infant, Premature
233 rdf:type schema:DefinedTerm
234 Nf0aaa6f5ed0b450e9be4278147b7c634 rdf:first sg:person.015404505305.76
235 rdf:rest N1522167bb20d4812ba4d3cb28ddcb7e0
236 Nf2ff0e08ea8e42a292683f63141d1517 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
237 schema:name Length of Stay
238 rdf:type schema:DefinedTerm
239 Nf4a0f439b559462891cc96a516c99142 schema:volumeNumber 36
240 rdf:type schema:PublicationVolume
241 Nf7ee38cc4186441b83c17f9b1ae3c058 rdf:first sg:person.01116472424.97
242 rdf:rest Nd7d00306804e42f4a75e0156ec90354a
243 Nfc2461f4fef841efa765f06b09e5b40c schema:name Springer Nature - SN SciGraph project
244 rdf:type schema:Organization
245 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
246 schema:name Medical and Health Sciences
247 rdf:type schema:DefinedTerm
248 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
249 schema:name Paediatrics and Reproductive Medicine
250 rdf:type schema:DefinedTerm
251 sg:journal.1095220 schema:issn 0743-8346
252 1476-5543
253 schema:name Journal of Perinatology
254 schema:publisher Springer Nature
255 rdf:type schema:Periodical
256 sg:person.01116472424.97 schema:affiliation grid-institutes:grid.418152.b
257 schema:familyName McLaurin
258 schema:givenName K K
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116472424.97
260 rdf:type schema:Person
261 sg:person.014011544305.49 schema:affiliation grid-institutes:None
262 schema:familyName Farr
263 schema:givenName A M
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011544305.49
265 rdf:type schema:Person
266 sg:person.015404505305.76 schema:affiliation grid-institutes:grid.460065.1
267 schema:familyName Diakun
268 schema:givenName D R
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404505305.76
270 rdf:type schema:Person
271 sg:person.0617012057.00 schema:affiliation grid-institutes:None
272 schema:familyName Wade
273 schema:givenName S W
274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00
275 rdf:type schema:Person
276 grid-institutes:None schema:alternateName Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA.
277 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA.
278 schema:name Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA.
279 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA.
280 rdf:type schema:Organization
281 grid-institutes:grid.266623.5 schema:alternateName Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children's Hospital, Louisville, KY, USA.
282 schema:name Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children's Hospital, Louisville, KY, USA.
283 rdf:type schema:Organization
284 grid-institutes:grid.418152.b schema:alternateName Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA.
285 schema:name Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA.
286 rdf:type schema:Organization
287 grid-institutes:grid.460065.1 schema:alternateName Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA.
288 schema:name Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA.
289 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...